These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
748 related articles for article (PubMed ID: 1653806)
1. Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation. Wenzel-Seifert K; Grünbaum L; Seifert R J Immunol; 1991 Sep; 147(6):1940-6. PubMed ID: 1653806 [TBL] [Abstract][Full Text] [Related]
2. Cyclosporin H is a potent and selective formyl peptide receptor antagonist. Comparison with N-t-butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L- leucyl-L-phenylalanine and cyclosporins A, B, C, D, and E. Wenzel-Seifert K; Seifert R J Immunol; 1993 May; 150(10):4591-9. PubMed ID: 8387097 [TBL] [Abstract][Full Text] [Related]
3. Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine. de Paulis A; Ciccarelli A; de Crescenzo G; Cirillo R; Patella V; Marone G J Allergy Clin Immunol; 1996 Jul; 98(1):152-64. PubMed ID: 8765829 [TBL] [Abstract][Full Text] [Related]
4. Formyl peptides and ATP stimulate Ca2+ and Na+ inward currents through non-selective cation channels via G-proteins in dibutyryl cyclic AMP-differentiated HL-60 cells. Involvement of Ca2+ and Na+ in the activation of beta-glucuronidase release and superoxide production. Krautwurst D; Seifert R; Hescheler J; Schultz G Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):1025-35. PubMed ID: 1281979 [TBL] [Abstract][Full Text] [Related]
5. Differential activation of dibutyryl cAMP-differentiated HL-60 human leukemia cells by chemoattractants. Klinker JF; Schwaner I; Offermanns S; Hagelüken A; Seifert R Biochem Pharmacol; 1994 Nov; 48(10):1857-64. PubMed ID: 7986196 [TBL] [Abstract][Full Text] [Related]
6. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis. Kew RR; Grimaldi CM; Furie MB; Fleit HB J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856 [TBL] [Abstract][Full Text] [Related]
7. Biphasic effects of cyclosporin A on formyl-methionyl-leucyl-phenylalanine stimulated responses in HL-60 cells differentiated into neutrophils. Nguyen NS; Pulido SM; Rüegg UT Br J Pharmacol; 1998 Aug; 124(8):1774-80. PubMed ID: 9756396 [TBL] [Abstract][Full Text] [Related]
8. Partial inhibition of human neutrophil activation by FK-506 at supratherapeutic concentrations. Wenzel-Seifert K; Seifert R Naunyn Schmiedebergs Arch Pharmacol; 1993 Jul; 348(1):7-13. PubMed ID: 7690907 [TBL] [Abstract][Full Text] [Related]
9. Nucleotide-, chemotactic peptide- and phorbol ester-induced exocytosis in HL-60 leukemic cells. Wenzel-Seifert K; Seifert R Immunobiology; 1990 Nov; 181(4-5):298-316. PubMed ID: 1966023 [TBL] [Abstract][Full Text] [Related]
10. Differential inhibition and potentiation by cell-permeant analogues of cyclic AMP and cyclic GMP and NO-containing compounds of exocytosis in human neutrophils. Wenzel-Seifert K; Ervens J; Seifert R Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):396-402. PubMed ID: 1722562 [TBL] [Abstract][Full Text] [Related]
11. Incomplete functional differentiation of HL-60 leukemic cells by synthetic lipopeptides. Partial inhibition by pertussis toxin of enhanced superoxide formation. Seifert R; Serke S; Huhn D; Bessler WG; Hauschildt S; Metzger J; Wismüller KH; Jung G Eur J Biochem; 1992 Jan; 203(1-2):143-51. PubMed ID: 1309696 [TBL] [Abstract][Full Text] [Related]
13. Differential uncoupling of chemoattractant receptors from G proteins in retinoic acid-differentiated HL-60 granulocytes. Erbeck K; Klein JB; McLeish KR J Immunol; 1993 Mar; 150(5):1913-21. PubMed ID: 8382247 [TBL] [Abstract][Full Text] [Related]
14. Rebamipide suppresses formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils. Nagano C; Azuma A; Ishiyama H; Sekiguchi K; Imagawa K; Kikuchi M J Pharmacol Exp Ther; 2001 Apr; 297(1):388-94. PubMed ID: 11259567 [TBL] [Abstract][Full Text] [Related]
15. Histamine inhibits activation of human neutrophils and HL-60 leukemic cells via H2-receptors. Burde R; Seifert R; Buschauer A; Schultz G Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6):671-8. PubMed ID: 2559336 [TBL] [Abstract][Full Text] [Related]
16. Molsidomine inhibits the chemoattractant-induced respiratory burst in human neutrophils via a no-independent mechanism. Ervens J; Seifert R Biochem Pharmacol; 1992 Aug; 44(4):637-44. PubMed ID: 1324680 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of spinorphin, a novel endogenous regulator, on chemotaxis, O2- generation, and exocytosis by N-formylmethionyl-leucyl-phenylalanine (FMLP)-stimulated neutrophils. Yamamoto Y; Kanazawa T; Shimamura M; Ueki M; Hazato T Biochem Pharmacol; 1997 Sep; 54(6):695-701. PubMed ID: 9310346 [TBL] [Abstract][Full Text] [Related]
19. Histamine increases cytosolic Ca2+ in dibutyryl-cAMP-differentiated HL-60 cells via H1 receptors and is an incomplete secretagogue. Seifert R; Höer A; Offermanns S; Buschauer A; Schunack W Mol Pharmacol; 1992 Aug; 42(2):227-34. PubMed ID: 1381043 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the plasma membrane bound GTPase from rabbit neutrophils. I. Evidence for an Ni-like protein coupled to the formyl peptide, C5a, and leukotriene B4 chemotaxis receptors. Feltner DE; Smith RH; Marasco WA J Immunol; 1986 Sep; 137(6):1961-70. PubMed ID: 3018082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]